Universidad Autonoma de Madrid
Posted: 13 November 2026 - Madrid, Spain
The Autonomous University of Madrid offers a 6-month postdoctoral contract to work on the project 'Evaluation of the efficacy and feasibility of a new nutraceutical as a therapeutic option for the prevention and treatment of fatty liver (MASLD) and steatohepatitis (MASH) associated with metabolic dysfunction'. The successful candidate will conduct cell culture experiments and process patient samples for genetic and metagenomic analysis using Sanger sequencing and next-generation sequencing (NGS) technologies. The role requires proficiency in molecular biology techniques, cell culture, and statistical analysis of large-scale data, with experience in patient sample handling and liver disease research considered advantageous.